Mdr resistance treatment

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 241/46 (2006.01) A61K 31/495 (2006.01) C07D 401/12 (2006.01)

Patent

CA 2144783

The invention concerns the new use of riminophenazines in the treatment of a patient who has built up, or could build up, resistance to a therapeutically active substance, such as a patient requiring treatment for cancer. The riminophenazine conveniently may be of the general formula (I). Image (I) R1 is a hydrogen atom, a halogen atom or an alkyl, aLkoxy or fluoroalkyl radical, R2 is a hydrogen or halogen atom, R3 is selected from hydrogen, alkyl, substituted alkyl, cycloalkyl, cycloalkylalkyl, or is a substituted or unsubstituted heterocyclic or heterocyclic-alkyl radical, R4 is a hydrogen or halogen atom or an alkyl, alkoxy or fluoroalkyl radical, and n is 1, 2 or 3. The invention also provides novel riminophenazines of general formula (I), their preparation, and compositions containing them.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mdr resistance treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mdr resistance treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mdr resistance treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1830649

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.